Treatment with radiosynoviorthesis in hemophilic patients with and without inhibitor.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: The authors declare that there is no conflict of interest. 18. Haemophilia. 2024 Mar;30(2):331-335. doi: 10.1111/hae.14939. Epub 2024 Jan 19. Joint bleeds in mild hemophilia: Prevalence and clinical characteristics. Chiari JB(1), Prozora S(2), Feinn R(3), Louizos E(2), Gallagher PG(4), Bona R(5). Author information: (1)Department of Surgery, Memorial Health University Medical Center, Savannah, Georgia, USA. (2)Department of Pediatrics, Hemophilia Treatment Center, Yale School of Medicine, New Haven, Connecticut, USA. (3)Frank H. Netter School of Medicine, Department of Medical Sciences, Quinnipiac University, North Haven, Connecticut, USA. (4)Wexner Research Institute at Nationwide Children's Hospital, Department of Pediatrics, Ohio State University, Columbus, Ohio, USA. (5)Department of Medicine, Hemophilia Treatment Center, Yale School of Medicine, New Haven, Connecticut, USA. INTRODUCTION: Joint bleeds are a common and frequent complication associated with hemophilia, increasing the risk of hemophilic arthropathy. It is important to define and characterize the presence of joint complications in mild hemophilia to develop strategies to mitigate disease burden. AIMS: To characterize the prevalence, clinical characteristics of joint bleeds, and risk factors that may lead to hemarthrosis in people with mild hemophilia. METHODS: Following Institutional Review Board approval, a retrospective chart review was conducted for patients with mild hemophilia seen at the Yale Hemophilia Treatment Center or Classical Hematology Program. RESULTS: The medical records of 70 patients were reviewed. Eighty one percent were male and 19 percent were female. Twenty individuals with mild hemophilia had a history of joint bleeding, 13 were traumatic bleeds, 7 were spontaneous. The age of first joint bleed ranged from 4 to 58 years old, with an average age of 20.8-years old. Ten patients developed joint bleeds between the ages of 10 and 20 years old. The most common locations of joint bleeding were the knee (n = 11) and ankle (n = 7). Eight of 70 patients had hepatitis C (HCV), 6 experienced joint bleeding. CONCLUSIONS: In this study, almost one third of patients with mild hemophilia experienced joint bleeding, often without history of trauma. Joint range of motion was abnormal in more than a third of the patients with mild hemophilia regardless. These data highlight the need for ongoing evaluation and characterization of joint health in individuals with mild hemophilia. HIGHLIGHTS: Twenty-nine percent of individuals with mild hemophilia had history of joint bleed. PwH and mild diseases with previous or current hepatitis C had higher likelihood of joint bleeding. Approximately 15% of PwH and mild diseases had abnormal joint examinations without a confirmed history of joint bleeding. © 2024 John Wiley & Sons Ltd. DOI: 10.1111/hae.14939